Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Increased emphasis on HCP engagement rules in new normal
Sanjay Mehta, Jt CEO, Mirum, explains several ways for pharma companies that would help those in engaging healthcare professionals…
AstraZeneca launches Clinical Data and Insights division in India
The CDI team in Bengaluru, India, is a critical advancement to support a growing global portfolio, and build on internal data…
Roche Pharma achieves several milestones in Q3
The company announced several key development milestones in neuroscience, ophthalmology, oncology and COVID-19, along with some…
WHO-led programme plans to purchase anti-viral COVID-19 pills for $10
Merck's experimental pill Molnupiravir is likely to be one of the drugs, and other drugs to treat mild patients are being…
Dr Reddy’s Lab receives US FDA approval to market Lenalidomide capsule
Dr Reddy's Laboratories today said it has received approval from the US health regulator to market Lenalidomide capsules
Valneva reports positive phase-III results for inactivated, adjuvanted COVID-19 vaccine candidate…
VLA2001 was well-tolerated, demonstrating a statistically significant better tolerability profile compared to active comparator…
Gender plays no role in leadership
Shalini Kamath, Independent Director on the Boards of Abbott, talks to Ashwini Prakash, Managing Partner India, Asia Pacific Lead…
mRNA COVID jabs as second dose may generate robust immune response: Lancet study
The study, published in the journal The Lancet Regional Health - Europe, points out the high effectiveness of mix-and-match…
Pfizer/BioNTech submit data to EMA for children’s COVID-19 vaccine
Although the vaccine is currently not allowed for that age group, it has been authorised for use in children over 12 years of age…
MSN Labs launches Empagliflozin tablets for diabetes management in India
The medicine will cost Rs 15.90 and Rs 18.90 for each 10 mg and 25 mg tablet, respectively